ROS1 inhibitor (ROSALINE trial)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ROS1 inhibitor (ROSALINE trial), covering 2024-12-04 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) [Phase 2]